Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
11/11/2019
/
Publications
/
Toxicity
Survival
Chemotherapy
This study from Taiwan retrospectively examined 30 patients with unresectable CC who were treated with PBT to a total dose of 72.6 GyRBE. The 1-year local...
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
11/12/2019
/
Publications
/
Hypofractionation
Survival
This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...
Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer.
01/01/2020
/
Publications
/
Survival
This paper reviews the current status of photon and particle radiation therapy for pancreatic cancer in combination with systemic therapies and hypoxia...
Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence.
01/01/2020
/
Publications
/
Chemotherapy
Survival
This study from Japan reported the efficacy of 44 clinical T1 esophageal cancer patients treated with concurrent chemo-proton therapy (CCPT). 43 patients (98%)...
The emerging role of proton therapy for esophagus cancer.
03/02/2020
/
Publications
/
Survival
This review article discussed the emerging role of PBT for esophageal cancer, including rationale, treatment planning, early dosimetric and clinical comparisons...
Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
03/03/2020
/
Publications
/
Survival
A study by the Samsung group from Korea published in the Green Journal. A total of 103 patients treated with proton therapy including 70 in the PS group and 33...
Proton Beam Therapy Is a Safe and Effective Treatment in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESCC).
05/06/2020
/
Publications
/
Toxicity
Survival
This study from Japan reported results of 54 esophageal cancer patients who are over 75 years old treated with PBT. 38 inoperable patients (70.4%) and 16...
Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer.
26/06/2020
/
Publications
/
Survival
The relatively higher cardiac dose exposure for esophageal cancer (EC) may result in the earlier onset of cardiac diseases. This MD Anderson study analyzed 479...
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
28/04/2020
/
Publications
/
Hypofractionation
Survival
Toxicity
Published by the NCC group in Korea, this study reported outcomes of 45 patients including 37 had recurrent and/or residual disease treated with PBT to a total...
PBT outcomes for localized unresectable hepatocellular carcinoma.
03/01/2019
/
Publications
/
Survival
Toxicity
A MD Anderson study published in the Green Journal reported outcomes of forty-six patients with HCC, Child-Pugh class of A or B, no prior radiotherapy treated...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.